Asia Pacific Cancer Immunotherapy Market By Technology (Monoclonal Antibodies, Cytokines & Immunomodulators), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer), End User (Hospitals, Clinics)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Cancer Immunotherapy Market
Market Report Description
The Asia Pacific Market would witness market growth of 16.5% CAGR during the forecast period (2018 – 2024). Cancer immunotherapy is the type of cancer treatment helping the immune system fight cancer. There are various kinds of cancer immunotherapies used and they are monoclonal antibody, therapeutic cancer vaccines, checkpoint inhibitors, cytokines, and others. Growing patient population that is suffering from different types of cancer such as lung cancer, breast cancer, ovarian cancer, and other cancers are the factors that drive the global cancer immunotherapy market. Additionally, growing geriatric population and governmental contribution to healthcare expenditure are some other factors that add to the market growth.
Based on technology, the market is segmented into Monoclonal Antibodies, Cytokines & Immunomodulators and other technology. Based on application, the market is segmented into Lung cancer, Breast cancer, Colorectal, Prostate cancer, Head & Neck cancer and other application. Based on end user the market is segmented into Hospitals, Clinics and other end user. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AstraZeneca, Amgen Inc., Eli Lilly and Company, Merck & Co., Inc., Bristol-Myers Squibb Company, Pfizer Inc., Bayer Ag, Immunomedics Inc., Novartis AG, F. Hoffmann-La Roche Ltd.
Scope of the Study
- Monoclonal Antibodies,
- Cytokines & Immunomodulators
- Other technology
- Lung cancer
- Breast cancer
- Prostate cancer
- Head & Neck cancer
- Other application.
By End User
- Other End User
- South Korea
- Rest of Asia Pacific
- Amgen Inc.
- Eli Lilly and Company
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Bayer Ag
- Immunomedics Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Global Cancer Immunotherapy Market (2018-2024)
Europe Cancer Immunotherapy Market (2018-2024)
North America Cancer Immunotherapy Market (2018-2024)